Abstract-Recent studies have indicated the importance of cholesterol-rich membrane lipid rafts (LRs) in oxidative stress-induced signal transduction. Reduced nicotinamide-adenine dinucleotide phosphate (NADPH) oxidases, the major sources of reactive oxygen species, are implicated in cardiovascular diseases, including hypertension. We tested the hypothesis that NADPH oxidase subunits and activity are regulated by LRs in human renal proximal tubule cells. We report that a high proportion of p22 phox and the small GTPase Rac1 are expressed in LRs in human renal proximal tubule cells. 
R educed nicotinamide-adenine dinucleotide phosphate (NADPH) oxidase, originally identified as a key component of human innate host defense, 1 and studied extensively in phagocytes, [1] [2] [3] has been subsequently studied in nonphagocytic cells, including gastrointestinal, neural, pulmonary, renal, and vascular smooth muscle cells. 4 -17 These studies provided evidence that this enzyme is the major source of reactive oxygen species (ROS) in nonphagocytic cells. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] In addition to mediating the intracellular killing of pathogens in leukocytes and macrophages, ROS may serve as signal transducers. However, ROS may also be important mediators of cell injury 6 -16 ; oxidative stress is thought to be important in the pathogenesis of hypertension. [15] [16] [17] The primary redox component of all NADPH oxidases is known as Nox, which has 7 isoforms: Nox1; gp91 phox (also termed Nox2); Nox3; Nox4; Nox5; Duox1; and Duox2. Nox 1 is mainly expressed in the colon, 2, 4 Nox2 was originally found in human neutrophils, [1] [2] [3] [4] 18, 19 Nox3 is expressed in fetal liver and the lung, Nox4 is found in the kidney, 4, 10, 11 Nox5 is present in spleen and sperm, and Duox1 and Duox2 are primarily found in the thyroid. However, these Noxs are also expressed in other tissues. 4 -16 In the kidney, renox/Nox4 (which is homologous to Nox2) is highly expressed in the proximal convoluted tubule, 10 whereas Nox4 is highly expressed in distal tubules. 11 Activation of Nox2 requires its assembly with a membrane subunit, p22 phox ; several cytosolic regulatory subunits, p67 phox , p47 phox , and p40 phox ; and small GTPase Rac. [1] [2] [3] 18, 19 Lipid rafts (LRs) are composed of glycosylphosphatidylinositollinked proteins, glycosphingolipids, and cholesterol that are associated with signaling molecules, eg, receptors such as G proteins. 20 There are several types of LRs, but the best described are the caveolae. 20 -23 These LRs are characterized by the presence of caveolins, which bind to cholesterol. Caveolar and noncaveolar LRs have been implicated in protein trafficking and signal transduction. 17,20 -23 We and others have reported that there are noncaveolar LRs in human embryonic kidney and rat renal proximal tubule cells because these cells are devoid of measurable caveolin-1 24, 25 and, therefore, could not form caveolae. 21, 24, 25 Nox2 and its subunits are distributed in and their activity regulated by LRs in murine microglial, bovine aortic endothelial, and bovine coronary arterial endothelial cells 26 -29 ; however, there are no such reports in nonphagocytic human cells. 30, 31 Dopamine is an important regulator of blood pressure and renal and adrenal function through an independent peripheral dopaminergic system. 32, 33 Abnormalities in renal dopamine production and receptor function have been described in human essential hypertension and rodent models of genetic hypertension. 32 ,33 D 1 -like dopamine receptor-mediated inhibition of NADPH oxidase activity has been reported by several groups, including ours. 34 -36 Those studies were performed in vascular smooth muscle cells in rats, renal tubules in mice, and embryonic kidney and peripheral blood mononuclear cells in humans. However, those reports did not describe the membrane microdomain localization of NADPH oxidase subunits and did not provide a cellular biological mechanism for the D 1 -like receptor-mediated inhibition of NADPH oxidase activity. We tested the hypothesis that NADPH oxidase subunits and activity are regulated by D 1 -like receptors in LRs of human renal proximal tubule (hRPT) cells. We now report for the first time that the majority of p22 phox and Rac1 are distributed in LRs, whereas Nox4 is excluded from LRs. Cholesterol depletion increased NADPH oxidase activity by redistributing NADPH oxidase subunits in non-LRs. In contrast, the D 1 -like receptor agonist (fenoldopam)-induced inhibition of oxidase activity was accompanied by the dispersal of Nox and subunits in LRs and non-LRs. These studies suggest that, in human nonphagocytic cells, LRs keep NADPH oxidase in the inactive state.
Methods
An expanded Methods section is available online at http://hyper. ahajournals.org.
Measurement of Nox Activity
Cells treated with the indicated drugs and whole cell membranes were prepared (see the supplemental data). NADPH oxidase activity was determined by measuring superoxide generation in whole cell membranes in the presence of lucigenin (10 mol/L) and NADPH (100 mol/L). 35, 37 The dynamic tracings of NADPH-dependent activity were recorded for 180 seconds (AutoLumat Plus luminometer, LB953, EG&G Berthhold). The activities were expressed as arbitrary light units (ALUs) corrected for the protein concentration and duration of the experiment (ALU/second per milligram of protein). To compare the control and drug treatment groups, the percentage difference of the absolute value of each drug treatment from the absolute mean of the controls was calculated. All of the assays were performed in duplicate. All of the protein concentrations were assayed via Bio-Rad kit.
In some experiments, ROS were measured in living cells. Cells (10 6 cells per well), seeded in 6-well plates and treated with drugs, were washed twice with the assay buffer and scraped into an assay tube. The assay was started by the addition of lucigenin and NADPH, and the dynamic tracing was recorded as described above. Activity is expressed as ALUs per well in dynamic tracing graph and converted to the percentage of change from control.
LR Labeling and Confocal Microscopy
LRs were labeled using the Vybrant LR labeling kit. Cells grown on coverslips were washed once with serum-free medium and incubated with cholera toxin subunit B conjugated with Alexa Fluor 400 (CTB-488) at 1.0 g/mL for 10 minutes at 4°C. The cells were washed and incubated with polyclonal anti-CTB antibody (1:200 dilution) for 15 minutes at 4°C. The cells were then stained with monoclonal anti-Nox2 or anti-p22 phox antibodies for 30 minutes. 24 Fluorescence images were obtained using laser confocal scanning microscopy (Olympus Fluoview FV600) at excitation and emission wavelengths of 488 nm and 505 nm, respectively. 24
Statistical Analysis
The data are expressed as meansϮSEMs: Significant differences between the 2 groups were determined by Student's t test. Significance among several groups was determined by 1-way factorial ANOVA followed by the Newman-Keuls test. PϽ0.05 was considered significant.
Results

Analysis of NADPH Oxidase Subunit mRNA in hRPT Cells
The expression of mRNA for Nox1, Nox2, Nox4, p22 38 is shown in Figure S1 .
Analysis of Nox and Subunit Proteins in Membranes From Sucrose Gradients by Immunoblotting
Less than 10% of the membrane proteins were recovered in LRs (fractions 2 to 6; Figure 1A) ; the LR marker protein, caveolin-1, was mainly found in LRs; the other LR marker, flotillin-1, was found in both LRs and non-LRs ( Figure  1A ). 26 -30 Dopamine D 1 and D 5 receptors also cofractionated with the LR markers but were found in non-LR membrane fractions as well ( Figure 1A) .
The basal distributions of Nox2, Nox4, and NADPH oxidase subunits in LR and non-LR fractions are shown in Figure 1B and 1C and Table S2 . The percentage of LR protein expressions, relative to total LR and non-LR were as follows: Nox2, 40.3%; p22 phox , 65.7%; and Rac1, 57.7% in LRs; Nox4 was almost exclusively expressed in non-LRs. p67 phox tended to be expressed more in LRs than in non-LRs; however, significance was not attained. p40 phox and p47 phox were mainly localized in non-LRs ( Figure S2 ). Fenoldopam shifted the Nox2 bands from fractions 4 and 5 to fraction 3; shifted p22 phox bands from fractions 4 and 5 to 3 and 4 in LRs and to fractions 10 to 12 in non-LRs; minimally shifted p67 phox band from fractions 5 to 3 and 4; and decreased Rac1 bands in fractions 5 and 4 and redistributed them to fractions 10 and 11 in non-LR fractions ( Figure  1B and 1C) . Fenoldopam also decreased the protein expression of p22 phox and Rac1 in LRs and Nox2 and Nox4 in non-LRs ( Figure 1D and Table S3 ). Moreover, fenoldopam altered the localization of some of the Nox2 and p22 phox from membranes into small intracellular vesicles ( Figure 1E ). Fenoldopam did not affect the distribution of p47 phox and minimally altered the distribution of p40 phox ( Figure S2 ).
Effect of D 1 -Like Receptor Agonist on NADPH Oxidase Activity in hRPT Cells
The fenoldopam-induced alterations in NADPH oxidase subunit localization were associated with a decrease in total cell membrane oxidase activity. Thus, fenoldopam decreased NADPH oxidase activity (69.3Ϯ3.3% versus control: 100Ϯ2.8%) that was blocked by the D 1 -like receptor antagonist, Sch23390 (101.1Ϯ3.0%), which by itself had no effect (98.2Ϯ6.8%; Figure 2 
Effect of Methyl-␤-Cyclodextrin on ROS Production and Membrane NADPH Oxidase Activity in hRPT Cells
To investigate the functional role of LRs in the regulation of NADPH oxidase, methyl-␤-Cyclodextrin (␤CD), a wellestablished cholesterol depleting reagent, was used to disrupt LRs. 21, 23, 24 The effects of ␤CD on ROS production are shown in Figure 3 and Table S4 . ␤CD dose-dependently increased ROS production, with the maximum effect noted at 15 mmol/L. This effect also increased with time, peaking at 60 minutes. A higher concentration (20 mmol/L) and a longer period of incubation (90 minutes) resulted in a decrease in ROS production relative to the previous dose or time period (Figure 3 ). Treatment of hRPT cells with ␤CD (2% per 1 hour at 37°C) decreased membrane cholesterol by 54.9Ϯ4.6%, (Figure S4 ), in agreement with previous reports. 21, 23 ␤CD treatment also resulted in a redistribution of Nox2 and other subunits toward the non-LR fractions 7 to 12 ( Figure 1B and 1C caveolin-1 is expressed ( Figure 1A ). In contrast, there are no caveolae in HEK-293 cells because they lack caveolin-1. 24 Nox2 and Nox4 are endogenously expressed in human kidney and HEK-293 cells. 4 D 1 -like receptors are endogenously expressed in hRPT cells 38 but not in HEK-293 cells. 39 Similar to the studies in hRPT cells, ␤CD increased Nox activity, which was completely reversed by cholesterol repletion ( Figure 4A and Table S5 ). Of note was the greater increase in NADPH oxidase activity caused by ␤CD in HEK-293 cells, which do not express either the D 1 or D 5 receptor. 39 This could be taken to indicate that NADPH oxidase activity may be negatively regulated by D 1 -like receptors, because HEK-293 cells that do not express D 1 -like receptors have higher Nox activity than cells that express them ( Figure 4A ).
To confirm that the stimulatory effect of ␤CD on NADPH oxidase activity in human kidney cells was also exerted in other human cells, human coronary artery smooth muscle cells (hCASMs), which also express caveolin-1, 40 were studied. In hCASMs, ␤CD also increased ROS production (8.5Ϯ1.0-fold), an effect that was partially reversed by cholesterol repletion ( Figure 4B ).
Effect of NADPH Oxidase Inhibitors on ␤CD-Mediated Stimulation of Oxidase Activity in Human Kidney Cells
To investigate the mechanisms responsible for the effect of ␤CD on NADPH oxidase activity in human kidney cells (hRPT and HEK-hD 1 ), oxidase inhibitors apocynin and diphenylene iodonium chloride (DPI) were used. The increased NADPH oxidase activity induced by ␤CD treatment was completely reversed by the addition of apocynin and DPI ( Figure 5 and Table S6 ) in both hRPT and HEK-hD 1 cells. Apocynin, by itself, had a modest inhibitory effect, whereas DPI, by itself, had a drastic inhibitory effect ( Figure 5 ). These results indicate that the disruption of LRs facilitates NADPH oxidase assembly, presumably in non-LRs, and promotes activation of the oxidase.
Effect of Knockdown of Nox2 and Nox4 on ␤CD-Induced Activation of Nox
To determine the specific Nox isoform that contributed to the enhanced ROS production induced by ␤CD, small interfering RNA (siRNA) was used to specifically knock down Nox2 or Nox4 expression. The Nox-specific siRNAs decreased the expression of Nox2 by 61% and Nox4 by 47% ( Figure S5 ). As shown in Figure 6 and Table S7 , knockdown of Nox2, by itself, had a slight and nonsignificant effect on basal ROS production. Knockdown of Nox4 by itself did not affect basal ROS production. However, knockdown of either Nox2 or Nox4 completely prevented the stimulatory effect of ␤CD on ROS production, indicating that both Nox2 and Nox4 contributed to the enhanced ROS production when LRs were disrupted.
Discussion
NADPH oxidases are now recognized to have specific subcellular localizations in caveolae LRs, endosomes, and nuclei. 17-21,26 -31 There are only few studies that have reported the distribution and regulation of Nox proteins and oxidase subunits in LRs, and most of the studies were performed in nonhuman cells, 26 -29 except those in human neutrophils. 30, 31 The novel findings are as follows: (1) NADPH oxidase subunits (p22 phox and Rac1) are mainly distributed in LRs rather than in non-LRs; (2) D 1 -like receptors (D 1 R and D 5 R) inhibit membrane NADPH oxidase activity that is accompanied by movement of Nox2 and subunits into more buoyant LR fractions or non-LR fractions and into intracellular vesicles; (3) cholesterol depletion with ␤CD increases membrane oxidase activity/ROS production; and (4) the stimulatory effect of cholesterol depletion is prevented by direct inhibition of NADPH oxidase or by knockdown of either Nox2 or Nox4 protein expression.
The current studies show that endogenously expressed Nox isoforms and oxidase subunits are regulated in caveolae-LRs and non-LRs. Of the NADPH oxidase subunits, p22 phox plays a key role in NADPH oxidase function. 4 Our studies show for the first time that cholesterol depletion caused an increase in membrane NADPH oxidase activity/ROS production in hRPT, HEK-293, and HEK-hD 1 cells, in response to cholesterol depletion, was also observed in hCASMs. However, cholesterol depletion in human neutrophils did not affect basal superoxide production. 30, 31 The mechanisms involved in the cell-specific regulation of NADPH oxidase activity by cholesterol remain to be determined.
There may also be species-specific membrane microdomain regulation of NADPH oxidase by cholesterol. Cholesterol depletion with ␤CD decreased ROS production in bovine 28, 29 and rodent cells. 26, 27 We have also found that cholesterol depletion of rat renal proximal tubule cells de- creased superoxide production (unpublished data). Transfection of rat p22 phox in HEK-293 cells heterologously expressing rat Nox4 caused a 3-fold increase in ROS production. 41 In contrast, transfection of human p22 phox in HEK-293 cells heterologously expressing human NADPH oxidase isoforms, Nox1 to 4, did not further increase ROS production. 12 These studies suggest inherent differences between human and rodent NADPH oxidase subunit activity, but the cause of such inherent differences remains to be discovered.
There are caveolae in rodent and bovine vascular smooth muscle and endothelial cells, 22, 23 similar to human RPT cells (current study) and human coronary arterial smooth muscle cells. 40 In contrast, there are no caveolae in human neutrophils, rat renal proximal tubules, and mouse microglial cells. 24, 25, 26, 30, 31 The effect of cholesterol-depleting drugs, eg, ␤CD, is because of cholesterol depletion and is not caused by nonspecific drug effects, because the drug-induced changes were reversed by cholesterol repletion. These studies support the notion that cholesterol, an important component of LRs, rather than caveolae mediates the effect of cholesterol depletion on basal oxidase activity and ROS production, be it stimulatory or inhibitory. The notion that the activation of NADPH oxidase with cholesterol depletion is secondary to translocation of NADPH oxidase subunits, resulting in its assembly and activation, is supported by the apocynin and DPI experiments. Apocynin and DPI, 2 structurally unrelated NADPH oxidase inhibitors, have been widely used in functional studies of NADPH oxidase. 5, 9, 11, 42 In the current report, both apocynin, which, by itself had a modest inhibitory effect on basal oxidase activity, and DPI, which by itself had a marked inhibitory effect, reversed the ␤CD-mediated increase in ROS production in hRPT and HEK-D 1 cells, indicating that NADPH oxidase is a major source of ROS production in these cells. In the basal state, cells produce low levels of ROS for self-defense, which requires only a minimal activation of Nox. Apocynin exerts its inhibitory effect by reacting with thiol groups and by inhibiting the translocation of cytosolic factors and their assembly with Nox2-p22 phox in the cell membrane. 9 DPI inhibits flavoprotein activity by direct binding and inhibition of mitochondrial electron transfer and NO synthase activity. 42 The pharmacological studies using apocynin and DPI do not directly prove the importance of redistribution of NADPH oxidase subunits in non-LRs in the stimulatory effect of cholesterol depletion on NADPH oxidase activity, and, thus, other mechanisms may be involved. However, the Nox2 and Nox4 knockdown studies minimize the need for such alternative explanations. Nox 2 4, 8, 13 and Nox4 are expressed in renal tubules, with Nox4 as the major isoform in the kidney. 4, 7, 8, 11 Inhibition of Nox2 or Nox4 protein expression in hRPT cells by Nox2 or Nox4 siRNA completely reversed the stimulatory effect of ␤CD on ROS production, suggesting that both Nox2 and Nox4 are critical in this phenomenon. Kawahara et al 12 phox and Rac1, could be because of translocation to non-LRs. The D 1 -like receptor-mediated decrease in the expression of Nox2 and Nox4 in non-LRs may have been the result of degradation; fenoldopam induced the movement of Nox2 into small intracellular vesicles (early or late endosomes), possibly en route to their degradation. This segregated compartmentalization of Nox and subunits would impair their assembly, similar to those described for apocynin, 9 resulting in decreased NADPH oxidase activity and ROS production. However, it remains to be determined how D 1 -like receptors regulate Nox2 and NADPH oxidase subunit degradation and trafficking along with the other receptors in LRs in hRPT cells.
In summary, we show for the first time that D 1 -like receptors regulate NADPH oxidase activity through the redistribution of Nox2 and subunits (p22 phox and Rac1) in membrane microdomains and intracellular vesicles. Disruption of LRs enhances NADPH oxidase activity and ROS production, which are abolished by antioxidant reagents and inhibition of Nox2 and Nox4 expression. Therefore, the integrity of LRs plays an important role in maintaining NADPH oxidase in the inactive state in human nonphagocytic cells.
Clinical Perspectives
The integrity of LRs plays an important role in keeping NADPH oxidase inactive in hRPT cells. Marked reductions in total cholesterol have beneficial effects on cardiovascular function. 43 A 50% decrease in cell membrane cholesterol is associated with oxidative stress, and oxidative stress is associated with disease, including hypertension. Thus, it is possible that the marked reduction in serum cholesterol obtained through pharmacological treatment could result in a decrease in cell membrane cholesterol and a potentially deleterious increase in oxidative stress.
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Materials and Methods
Materials
Previously well-characterized human renal proximal tubule (hRPT) cells were used (1-3).
The sources of reagents were: monoclonal antibodies to human NADPH oxidase subunits (Nox2, 
Cell Culture
The hRPT cells from normotensive subjects were maintained in DMEM/F12
supplemented with 10% fetal bovine serum (FBS), epidermal growth factor (10 ng/ml), insulin, transferrin, selenium (5 µg/ml each), hydrocortisone (36 ng/ml) and triiodothyronine (4 pg/ml) at 
Cell transfections
Cells were seeded in 6-well plates at density of 2x10 5 /well at day 1 and then transfected with siRNA for Nox2 or Nox4 or control siRNA at day 2, following the manufacturer's directions. ROS, assayed at day 4, as described in 'Methods', were expressed as ALU/well (10 6 cells/well). The results were compared with controls that were given a value of 100%.
Reverse transcription-polymerase chain reaction (RT-PCR) analysis
RNA was extracted from hRPT cells, using the RNeasay RNA Extraction Kit (Qiagen)
following the manufacturer's directions. Total RNA was quantified by Smartspec TM Plus (BioRad) and 1 µg of RNA was used to semi-quantify the mRNA expression of Nox2 and Nox4.
The sets of the primers are listed in Supplement Table S1 . 
RT-PCR was carried out using
Whole cell membrane preparation
Cell membranes were prepared, as described previously (10) with slight modifications.
Briefly, hRPT cells were treated with the indicated drugs. The cell pellets were collected after centrifugation (1000g/2min/4 o C), washed with cold PBS, and re-suspended in 500 µl of ice-cold hypotonic lysis buffer containing (concentration in mmol/L, shown in square brackets) Tris-HCl [25] , EDTA [1] , and EGTA [1] , and protease inhibitors, pH 7.4. The cell suspensions were sonicated and centrifuged at 1000 g for 10 min. The supernatants were collected, the pellets were re-suspended in lysis buffer, and the sonication and centrifugation steps were repeated. The supernatants were combined and centrifuged at 425,000 g for 60 min. The pellets containing whole cell membranes were resuspended in assay buffer containing (mmol/L) sodium phosphate [10] 
Subcellular fractionation
To prepare LRs and non-LRs, hRPT cells were subjected to sucrose density gradient centrifugation using a detergent-free protocol according to Song (15) , with slight modifications (9) . Briefly, the cell pellets were lysed in 1.5 ml of 500 mmol/L sodium carbonate, pH 11, and homogenized in clear ultracentrifuge tubes. Equal amounts of homogenates (for each group of samples) were diluted 1:2 with 80% sucrose and overlaid with 5-35% sucrose as a discontinuous sucrose gradient and subjected to centrifugation at 160,000 g (Beckman SW40 rotor) at 4 o C for 16 hours. After centrifugation, twelve 1-ml fractions were collected, and a light-scattering band confined to the 5-35% sucrose interface were in fractions 2-6 and represent lipid rafts (LRs) while fractions 7-12 represent non-LRs (9, 15, 16) . Caveolin-1 and flotillin-1, which are strongly associated with LRs, and considered as LRs marker proteins (12), co-fractionated with these LRs fractions (9, (12) (13) (14) (15) . All sucrose solutions were prepared in MBS (mmol/L) Mes [25] , pH 6.7, NaCl [150] . The fractionated proteins were mixed with Laemmli buffer, boiled, and subjected to immunoblotting (9) .
Immunoblotting
To assess the quantity of proteins in the sucrose gradient fractions, 30 µl from each of the twelve fractions were subjected to SDS-polyacrylamide gradient (8-16%) gel electrophoresis and transferred onto nitrocellulose membranes. The membranes were probed with the indicated antibodies, and the immunoreactive bands were quantified as reported (9, 16, 17) . Proteins of interest were normalized to control groups, with the control given a value of 100%. All protein preparations were carried out at 4 o C in the presence of protease inhibitors (Cocktail set III), as described above. All protein concentrations were assayed with a Bio-Rad kit.
Measurement of cholesterol content
Cholesterol content was measured using the Amplex Red cholesterol assay kit following the manufacturer's directions (18) . hRPT cells were grown in 6-well plates to 90% confluence. 
